U.S. Food and Drug Administration (FDA) warnings on the risk of suicidal thoughts and behaviors in children and adolescents taking antidepressants appear to be effective, according to a new study.

The FDA recommended in 2003 that paroxetine hydrochloride not be used to treat young people because of potential increased risk of suicidal behavior

The American College of Obstetricians and Gynecologists says women should consult their doctor if they are taking antidepressant medicine while they are pregnant.

The association's Committee on Obstetric Practice singled out Paxil (also known as paroxetine) saying the drug has been linked to some problems with the baby

Contrary to previous studies, a new report in the March issue of the Harvard Mental Health Letter finds that selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants are relatively safe for pregnant women.

But, an FDA warning last year, that said women who took the SSRI paroxetine (Paxil) during the first trimester had an increased risk of birth defects and might develop transient withdrawal symptoms, has many women reconsidering their options

The Food and Drug Administration warns that a recent study suggests the antidepressant Paxil may be associated with birth defects.

Paxil's manufacturer, GlaxoSmithKline, says it will include the results of the study in the drug's precaution list